<DOC>
	<DOCNO>NCT00391911</DOCNO>
	<brief_summary>Rhabdomyolysis many cause include trauma , muscle crush injury , lack blood supply arm leg , burn , seizure , drug hereditary disorder . Rhabdomyolysis cause breakdown muscle cell release molecule call myoglobin . Myoglobin harmful kidney lead kidney failure . Continuous dialysis show remove myoglobin molecule blood patient rhabdomyolysis . N-Acetylcysteine ( NAC ) use patient receive contrast dye x-rays show less worsen kidney function compare patient receive NAC . Early aggressive treatment patient rhabdomyolysis standard therapy , continuous dialysis drug call N-acetylcysteine ( NAC ) may prevent development acute kidney failure . Patients develop kidney failure disorder often critically ill much high chance survive develop kidney failure . The purpose study determine use NAC Continuous Veno-Venous hemo ( dia ) filtration ( CRRT ) early course rhabdomyolysis ( addition standard therapy ) decrease chance develop acute renal failure</brief_summary>
	<brief_title>Study N-Acetylcysteine ( NAC ) Continuous Renal Replacement Therapy ( CRRT ) Treatment Rhabdomyolysis</brief_title>
	<detailed_description>Rhabdomyolysis may define clinical biochemical syndrome may result large variety disease , trauma , toxic insult skeletal muscle . The damage integrity sarcolemma skeletal muscle lead release potentially toxic muscle cell component circulation , specifically myoglobin plasma . The three main principal therapy myoglobinuric renal failure include 1 ) correction hypovolemia/ renal ischemia , 2 ) increase clearance heme proteins circulation kidney , 3 ) attenuate adverse effect heme protein proximal tubule epithelium . Consequently , therapy rhabdomyolysis limit aggressive rehydration Ringer 's lactate normal saline , force diuresis mannitol , urinary alkalinization intravenous bicarbonate . Hypothesis 1 . The use N-acetylcysteine ( NAC ) continuous veno-venous hemo ( dia ) filtration ( CRRT ) early course rhabdomyolysis adjunct 'standard therapy ' ( rehydration , mannitol diuresis , systemic alkalinization ) respectively decrease nephrotoxicity improve elimination systemic myoglobin . Consequently therapies independently prevent deterioration renal glomerular tubular function establishment acute renal failure . 2 . There exist positive interaction use N-acetylcysteine CRRT prevention acute renal failure secondary rhabdomyolysis . Objectives Primary objective compare creatinine myoglobin clearance well glomerular filtration rate course 192 hour patient rhabdomyolysis treat NAC , early CRRT , CRRT NAC neither two therapy . Secondary objective : 1 ) Compare excretion urine B-NAG , B1-macroglobulin , microalbumin , indicator renal tubular glomerular damage course 192 hour subject rhabdomyolysis treat NAC , early CRRT , therapy , neither therapy 2 ) To compare ICU hospital mortality length stay well proportion subject recovery renal function 14 28 day follow randomization patient rhabdomyolysis treat NAC , early CRRT , therapy , neither therapy 3 ) To determine clinical biochemical risk factor renal failure development subject rhabdomyolysis .</detailed_description>
	<mesh_term>Rhabdomyolysis</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>1 . Randomization within 96 hour medical surgical diagnosis consistent rhabdomyolysis 2 . &gt; 18 yr old 3 . Meeting one following ( estimate ARF risk &gt; 20 % ) CK &gt; 25,000 IU/L Injury Severity Score &gt; 16 CK &gt; 5000 IU/L Age &gt; 55 CK &gt; 5000 IU/L 4 . Clinical suspicion high probability develop acute renal failure 5 . Informed consent 1 . Allergic reaction Nacetylcysteine . 2 . Previous wish include dialysis part medical therapy . 3 . Clinical biochemical indication dialysis ultrafiltration time screening : Massive fluid overload unresponsive diuretic require ultrafiltration . Refractory acidosis persistent serum pH &lt; 7.20 despite HCO3 therapy . Hyperkalemia EKG change necessitate dialysis removal potassium . Pericardial friction rub uremic pericarditis . 4 . RIFLE category Failure define one : Increase serum creatinine x 3 , GFR decrease 75 % OR SCreat ≥ 4mg/dl ( 354 umol/L ) ( acute rise ≥ 0.5mg/dl [ 44 umol/L ] ) UO &lt; 0.3ml/kg/h x 24h anuria x 12 hour 5 . RIFLE category Loss persistent ARF =complete loss kidney function &gt; 4 week 6 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Rhabdomyolysis</keyword>
	<keyword>CRRT</keyword>
	<keyword>N-Acetylcysteine</keyword>
</DOC>